E.F. Eriksen

869 total citations
27 papers, 664 citations indexed

About

E.F. Eriksen is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, E.F. Eriksen has authored 27 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Orthopedics and Sports Medicine, 15 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in E.F. Eriksen's work include Bone health and osteoporosis research (20 papers), Bone health and treatments (15 papers) and Bone Metabolism and Diseases (10 papers). E.F. Eriksen is often cited by papers focused on Bone health and osteoporosis research (20 papers), Bone health and treatments (15 papers) and Bone Metabolism and Diseases (10 papers). E.F. Eriksen collaborates with scholars based in Denmark, Norway and United States. E.F. Eriksen's co-authors include F. Melsen, Earl W. Sod, Arkadi Chines, I Barton, Moustapha Kassem, Carol L. Paddock, Eleftherios P. Paschalis, Rogely Boyce, Adele L. Boskey and John R. Gleason and has published in prestigious journals such as Journal of Bone and Mineral Research, Bone and Osteoporosis International.

In The Last Decade

E.F. Eriksen

25 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.F. Eriksen Denmark 14 522 361 228 79 79 27 664
Douglas W. Axelrod United States 7 498 1.0× 465 1.3× 319 1.4× 60 0.8× 68 0.9× 13 847
PD Delmas France 5 438 0.8× 355 1.0× 211 0.9× 64 0.8× 75 0.9× 11 712
E Boling United States 5 429 0.8× 299 0.8× 237 1.0× 63 0.8× 55 0.7× 7 590
Dietrich Wenderoth United Kingdom 9 825 1.6× 649 1.8× 373 1.6× 85 1.1× 158 2.0× 13 948
Amer Budayr United States 10 205 0.4× 384 1.1× 183 0.8× 49 0.6× 89 1.1× 12 621
Sanchita Agarwal United States 13 334 0.6× 159 0.4× 143 0.6× 74 0.9× 125 1.6× 42 561
Pietra Pennisi Italy 10 267 0.5× 150 0.4× 203 0.9× 72 0.9× 100 1.3× 13 594
M. Tellez United Kingdom 13 237 0.5× 192 0.5× 99 0.4× 62 0.8× 97 1.2× 23 513
Polly Young United States 11 376 0.7× 148 0.4× 130 0.6× 63 0.8× 212 2.7× 12 635
Roberto Valenti Italy 9 384 0.7× 173 0.5× 207 0.9× 120 1.5× 97 1.2× 15 611

Countries citing papers authored by E.F. Eriksen

Since Specialization
Citations

This map shows the geographic impact of E.F. Eriksen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.F. Eriksen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.F. Eriksen more than expected).

Fields of papers citing papers by E.F. Eriksen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.F. Eriksen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.F. Eriksen. The network helps show where E.F. Eriksen may publish in the future.

Co-authorship network of co-authors of E.F. Eriksen

This figure shows the co-authorship network connecting the top 25 collaborators of E.F. Eriksen. A scholar is included among the top collaborators of E.F. Eriksen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.F. Eriksen. E.F. Eriksen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gamsjaeger, Sonja, E.F. Eriksen, & Eleftherios P. Paschalis. (2021). Effect of hormone replacement therapy on bone formation quality and mineralization regulation mechanisms in early postmenopausal women. Bone Reports. 14. 101055–101055. 5 indexed citations
2.
Ahmed, Luai A., Rajesh Shigdel, Ragnar M. Joakimsen, et al.. (2015). Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures. Osteoporosis International. 26(8). 2137–2146. 57 indexed citations
3.
Finnes, Trine, Cathrine M. Lofthus, Helmut E. Meyer, et al.. (2014). Procollagen type 1 amino-terminal propeptide (P1NP) and risk of hip fractures in elderly Norwegian men and women. A NOREPOS study. Bone. 64. 1–7. 15 indexed citations
4.
5.
Lyles, Kenneth W., Cathleen Colón‐Emeric, Jay Magaziner, et al.. (2010). EFFICACY AND SAFETY OF ZOLEDRONIC ACID 5 MG IN PREVENTING FRACTURES IN MEN AND WOMEN AFTER HIP FRACTURE. 332–332. 1 indexed citations
6.
Cosman, Felicia, E.F. Eriksen, Christopher Recknor, et al.. (2010). Effects of once-yearly zoledronic acid 5mg in combination with teriparatide (PTH) on postmenopausal women with osteoporosis. Bone. 47. S55–S56. 2 indexed citations
7.
Devogelaer, J.-P., Jacques P. Brown, P. Burckhardt, et al.. (2007). Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis. Osteoporosis International. 18(9). 1211–1218. 51 indexed citations
8.
Devogelaer, Jean‐Pierre, P. Burckhardt, P Meunier, et al.. (2006). Zoledronic acid safety and efficacy over 5 years in post-menopausal osteoporosis. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
9.
Eriksen, E.F., F. Melsen, Earl W. Sod, I Barton, & Arkadi Chines. (2002). Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. Bone. 31(5). 620–625. 170 indexed citations
10.
Eriksen, E.F., et al.. (2001). Effect of 5-year risedronate therapy on fracture reduction and bone histology and histomorphometry. Open Repository and Bibliography (University of Liège). 1 indexed citations
11.
Kveiborg, Marie, Allan Flyvbjerg, E.F. Eriksen, & Moustapha Kassem. (2001). 1,25-Dihydroxyvitamin D3 stimulates the production of insulin-like growth factor-binding proteins-2, -3 and -4 in human bone marrow stromal cells. European Journal of Endocrinology. 144(5). 549–557. 30 indexed citations
12.
Ejersted, Charlotte, H. Oxlund, E.F. Eriksen, & T. T. Andreassen. (1998). Withdrawal of Parathyroid Hormone Treatment Causes Rapid Resorption of Newly Formed Vertebral Cancellous and Endocortical Bone in Old Rats. Bone. 23(1). 43–52. 32 indexed citations
13.
Eriksen, E.F., et al.. (1997). The Pathogenesis of Osteoporosis. Hormone Research. 48(5). 78–82. 20 indexed citations
14.
15.
16.
Boyce, Rogely, et al.. (1995). The effects of risedronate on canine cancellous bone remodeling: Three-dimensional kinetic reconstruction of the remodeling site. Journal of Bone and Mineral Research. 10(2). 211–221. 66 indexed citations
17.
Kassem, Moustapha, Kim Brixen, Werner Blum, L Mosekilde, & E.F. Eriksen. (1994). No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis. European Journal of Endocrinology. 131(2). 150–155. 34 indexed citations
18.
Eriksen, E.F., et al.. (1993). Bone remodeling during calcitonin excess: Reconstruction of the remodeling sequence in medullary thyroid carcinoma. Bone. 14(3). 399–401. 1 indexed citations
19.
Steiniche, Torben, et al.. (1992). Reconstruction of the formative site in trabecular bone by a new, quick, and easy method. Bone. 13(2). 147–152. 27 indexed citations
20.
Thomsen, Kristine Rømer, et al.. (1989). Seasonal variation of serum bone GLA protein. Scandinavian Journal of Clinical and Laboratory Investigation. 49(7). 605–611. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas W. Axelrod Breakdown of academic impact, for papers by PD Delmas Breakdown of academic impact, for papers by E Boling Breakdown of academic impact, for papers by Dietrich Wenderoth Breakdown of academic impact, for papers by Amer Budayr Breakdown of academic impact, for papers by Sanchita Agarwal Breakdown of academic impact, for papers by Pietra Pennisi Breakdown of academic impact, for papers by M. Tellez Breakdown of academic impact, for papers by Polly Young Breakdown of academic impact, for papers by Roberto Valenti
Rankless by CCL
2026